There are many choices of drugs when treating RA including numerous DMARDS and biologicals. Most of the currently used RA drugs are relatively new being developed and marketed in the past few years. In an earlier post, I documented that there are dozens of new RA drugs in the development pipeline. Do you wonder where all these new drugs for RA come from? Who develops them? How are they proven to work? What’s the difference between small and large molecule drugs? What are biosimilars? How are new drugs approved for use? How are they marketed? Who pays for the development?
If you want to learn more about these topics, I invite you to join me by taking a short online course from the University of California San Diego called
The instructors are Williams S. Ettouati and Joseph D. Ma who are professors of pharmacy at UC San Diego.
This course is what is called a MOOC which stands for Massive Open Online Course. Massive – Many people from a variety of backgrounds will be in the course, sometimes thousands. There are already over 12,000 people registered for this course! Open – It’s open to anyone and they are free. Online – All of the course activities and information are totally online. These courses are more about connecting and collaborating rather than taking a passive traditional course. MOOCs are rapidly becoming a popular way to take a course from a leading university taught by well known experts in the field. Check out this video and resource if you want to know more about MOOCs. This course is delivered through Coursera which is a leading provider of MOOCs by universities all over the world.
Join me if you want to learn more about this topic which is closely related to RA drugs. This particular course starts April 19 and is 9 weeks long. You’ll probably spend a couple of hours a week reading material and interacting with students. Let me know by sending me an email if you plan to take the course and I’ll look for you online. You can register through the Coursea website.